Public healthcare system utilization for chronic hepatitis C infection in Vietnam

Public healthcare system utilization for chronic hepatitis C infection in Vietnam

Abstract Background Healthcare utilization is typically adversely affected when the treatment is expensive and requires multiple visits. We examined the determinants of healthcare-seeking for Hepatitis C virus (HCV) infection which is asymptomatic, chronic, and requires costly treatment in an urban...

Full description

Bibliographic Details
Main Authors:	Phuong Nguyen Thi Ngoc, Ngoc Nghiem My, Sabrina Rasheed, Fatema Khatun, Jennifer Van Nuil, Dung Nguyen Thanh, Hung Le Mạnh, Motiur Rahman
Format:	Article
Language:	English
Published:	BMC 2023-11-01
Series:	BMC Infectious Diseases
Subjects:	Gender Hepatitis C virus Health insurance Determinants HCV treatment Hospital visits
Online Access:	https://doi.org/10.1186/s12879-023-08726-7

Similar Items

Mapping for Engagement: Setting up a Community Based Participatory Research Project to Reach Underserved Communities at Risk for Hepatitis C in Ho Chi Minh City, Vietnam
by: Giang Nguyen Quoc, et al.
Published: (2022-02-01)

Molecular characterization of hepatitis B virus in Vietnam
by: Thi Ton Taht Bui, et al.
Published: (2017-08-01)

Detection and Characterization of Human Pegivirus 2, Vietnam
by: Nguyen To Anh, et al.
Published: (2018-11-01)

Public healthcare system utilization for chronic hepatitis C infection in Vietnam
by: Thi Ngoc, PN, et al.
Published: (2023)

Confirmation of HCV viremia using HCV RNA and core antigen testing on dried blood spot in HIV infected peoples who inject drugs in Vietnam
by: Truong Tam Nguyen, et al.
Published: (2018-12-01)

Balancing uncertainty and proactivity in care seeking for hepatitis C: qualitative research with participants enrolled in a treatment trial in Ho Chi Minh City, Vietnam
by: My Nguyen Le Thao, et al.
Published: (2022-12-01)

Clinical and epidemiological features of chronic hepatitis C in the north-western region of Ukraine
by: T. I. Bevz
Published: (2020-02-01)

Factors Affecting Business Angels Investment in Vietnam
by: Nguyen Thi Kim Anh, et al.
Published: (2023-02-01)

Detection and distribution of genotypes of Hepatitis C in a tertiary care hospital
by: Upasana Bhumbla, et al.
Published: (2020-01-01)

Respiratory complications after surgery in Vietnam: National estimates of the economic burden
by: Bui My Hanh, et al.
Published: (2021-05-01)

Impact of working capital management on firm profitability: Empirical study in Vietnam
by: Nguyen Thi Thanh Phuong, et al.
Published: (2020-03-01)

Factors Affecting Decision to Participate Bancassurance: Evidence from Individual Customers in the South of Vietnam
by: Khuu Thi Phuong Dong, et al.
Published: (2024-09-01)

A Telementoring Program and Hepatitis C Virus Care in Rural Patients
by: Ping Du, et al.
Published: (2021-05-01)

Low intrafamilial transmission of hepatitis C virus in Central Brazil
by: R. M. B. Martins, et al.
Published: (1994-12-01)

Do differences exist between chronic hepatitis C genotypes 2 and 3?
by: Isaura Cunha Melo, et al.

HCV core antigen is an alternative marker to HCV RNA for evaluating active HCV infection: implications for improved diagnostic option in an era of affordable DAAs
by: Rujipat Wasitthankasem, et al.
Published: (2017-11-01)

HCV RNA Quantification by a Domestic Commercial Assay: A Case Study among People Who Inject Drugs in Vietnam
by: Quynh Bach Thi Nhu, et al.
Published: (2023-11-01)

Clinical and virological features of acute HBV-related hepatitis in southern Vietnam
by: Yen-Xuan Thi Nguyen, et al.
Published: (2006-04-01)

The patient voice: a survey of worries and anxieties during health system transition in HIV services in Vietnam
by: Shoko Matsumoto, et al.
Published: (2020-01-01)

A crossectional investigation of the relationship between complementary health insurance and frequency of dental visits in 15 to 64 years old of Tehran population, Iran, a secondary data analysis (urban HEART-2)
by: Morteza Rostam Beigi, et al.
Published: (2019-09-01)

Evaluation of Two-Assay Serological Testing Strategies for Anti-HCV Screening in Italian Populations: A Dual Screening Approach
by: Elena Zocca, et al.
Published: (2024-03-01)

Directly Acting Antiviral-Based Treatment for HCV-Infected Persons Who Inject Drugs: A Multicenter Real-Life Study
by: Vincenzo Messina, et al.
Published: (2020-12-01)

HEPATITIS C VIRUS INFECTION AND LYMPHOMA
by: Felipe Suarez, et al.
Published: (2010-02-01)

HEPATITIS C VIRUS INFECTION AND LYMPHOMA
by: Emmanuel Bachy, et al.
Published: (2010-03-01)

Prevalence of Hepatitis C Virus Infection Among Blood Donors and Certain Risky Groups in Diyala Province
by: Nadhim Ghazal Noaman
Published: (2019-11-01)

Prevalence of Hepatitis C Virus Infection Among Blood Donors and Certain Risky Groups in Diyala Province
by: Nadhim Ghazal Noaman
Published: (2019-11-01)

Hepatitis C and hemodialysis: a review
by: Regina Célia Moreira, et al.

EFFICACY OF FIRST AVAILABLE DIRECT-ACTING ANTIVIRAL AGENT IN TREATMENT OF CHRONIC HEPATITIS C; RESULTS FROM A SINGLE CENTRE IN PAKISTAN
by: Arif Qayyum Khan, et al.
Published: (2020-12-01)

HCV RNA positivity among hepatitis C patients in Chongqing, China from 2004 to 2021: a cross-sectional study
by: Yaping He, et al.
Published: (2024-11-01)

Elimination of HCV Infection: Recent Epidemiological Findings, Barriers, and Strategies for the Coming Years
by: Pietro Torre, et al.
Published: (2024-11-01)

Occult hepatitis C virus infection in Iranian hemodialysis patients
by: Ali Eslamifar, et al.
Published: (2015-10-01)

Evaluation of five screening tests licensed in Argentina for detection of hepatitis C virus antibodies
by: Viviana Ré, et al.
Published: (2005-05-01)

Prevalence of Hepatitis C Virus Infection, Genotypes and Subtypes in Migrants from Pakistan in Barcelona, Spain
by: Dopico E, et al.
Published: (2022-08-01)

Differential prevalence and geographic distribution of hepatitis C virus genotypes in acute and chronic hepatitis C patients in Vietnam.
by: Chau Le Ngoc, et al.
Published: (2019-01-01)

FEATURES OF CIRCULATION OF HEPATITIS C VIRUS IN KHABAROVSK REGION
by: N. V. Soboleva, et al.
Published: (2017-06-01)

Hepatitis C prevalence and risk factors in Georgia, 2015: setting a baseline for elimination
by: Liesl M. Hagan, et al.
Published: (2019-05-01)

Hepatitis C virus infection in a Brazilian population with sickle-cell anemia
by: M.C.M.R. Torres, et al.
Published: (2003-03-01)

Prevalence of anti-hepatitis C virus antibodies in pregnant women and their offspring in a tertiary hospital in Southwestern Nigeria
by: Paul Sunday Ogunro,1 Daniel Adebode Adekanle,2 Francis Folorunso Fadero,3 Titus Olabisi Ogungbamigbe,4 Samuel Olorunyomi Oninla.3
Published: (2007-12-01)

Peginterferon still has a place in the treatment of hepatitis C caused by genotype 3 virus
by: Aline Vitali Grando, et al.
Published: (2017-11-01)

HCV and HIV co-infection among people who inject drugs in Vietnam
by: Vu Toan THINH, et al.
Published: (2020-12-01)